Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Novaliq Gains US Approval of Vevye for the Signs and Symptoms of Dry Eye
Novaliq, of Heidelberg, Germany, reported June 8 that the US FDA had approved Vevye (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. June 8 wa...
CorNeat Vision Gains US Clearance for EverPatch Ophthalmic Graft Material
Israel-based CorNeat Vision reported June 8 that the US FDA had cleared itsEverPatch scleral reinforcement patch. The graft is the first synthetic, nondegradable tissue-integrating matrix for use i...
HanAll’s Dry Eye Candidate Tanfanercept Misses Primary Endpoints in Phase III Trial
South Korea-based HanAll Biopharma reported May 19 that its topical anti-inflammatory dry eye candidate tanfanercept missed its primary endpoints in the Phase III VELOS-3 trial. Tanfanercept did no...
Merck Sues US Government Over Medicare Drug Price Negotiation Program
Merck on June 6 sued the US Department ofHealth and Human Services (HHS) over Medicare’s plans to reduce drug prices under the Inflation Reduction Act of 2022, calling the price negotiation process...
Researchers Use AI to Find Better Drug Delivery Methods to Treat Glaucoma, Other Eye Disease
Researchers at Johns Hopkins’ Wilmer Eye Institute reported May 24 that they and colleagues from the University of Maryland had used machine learning—a method employed to create artificial intellig...
Sightpath Integrates Another Mobile Business Into Services
Sightpath Medical, of Bloomington, Minnesota, announced June 5 that it would integrate Southern Surgical Support, a Knoxville, Tennessee, mobile cataract services company, into its business. The mo...
BioLight, Alexion Team Up on Diagnosis of Retinal Disease Through Tear Film
Israel’s BioLight Life Sciences and Alexion announced May 30 that they would collaborate on a study of new technology that has the potential to screen the tear film to diagnose retinal disease. The...
US FDA Accepts NDA for Vyluma’s Pediatric Myopia Candidate
Vyluma announced June 6 that the US FDA had accepted its new drug application (NDA) for lead compound NVK002 (low dose atropine 0.01%) for childhood myopia and set a Prescription Drug User Fee Act ...
CoFi Raises $3.5 Million to Support Ophthalmic Payment Platform
Boston-based CoFi reported June 6 that it had closed a $3.5 million seed funding round. CoFi provides a multi-party payment platform for eye care practices offering elective ophthalmic procedures. ...
Oculis Reports Positive Topline Results in Phase III Trial of Eye Drop Candidate for DME
Swiss company Oculis reported May 22 positive topline results from the first stage of its Phase III trial of OCS-01 eye drops in diabetic macular edema (DME). OCS-01 is a high-concentration, topica...
Hoya Recalls Vivinex iSert Toric IOLs
Hoya Surgical Optics has issued a recall in India and Australia of eight models of its Vivinex iSert Toric IOL manufactured from June 2022 to January 2023. India’s Central Drugs Standard Control Or...
Roche Withdraws European Marketing Application for Susvimo
The European Medicines Agency (EMA) announced on May 25 that Swiss drugmaker Roche had withdrawn its marketing application for Susvimo, a refillable ocular implant for ranibizumab in wet age-relate...
Past News Stories
Redwood Pharma Reports Positive Results for RP501 Topical Candidate in Dry Eye
Sweden’s Redwood Pharma reported May 31 positive results from a clinical trial of RP501, the company’s IntelliGel-based topical first-line therapy candidate for dry eye disease. RP501 was safe and ...
Bausch + Lomb Elevates Business Unit Heads to Executive Management Team
Bausch + Lomb Chairman and Chief Executive Officer Brent Saunders continues to reshape his leadership team, after making his return to the company in February. The company announced June 1 that bus...
Stada, Xbrane Launch Ximluci Ranibizumab Biosimilar in Germany
Sweden’s Xbrane Biopharma and its partner Stada, of Germany, announced May 26 that they had launched their ranibizumab biosimilar Ximluci in Germany. The biosimilar was approved in Europe in Novemb...
Annexon’s Complement Therapy Candidate in GA Shows Preservation of Vision in Phase II Trial
Annexon reported May 24 that topline results from its ARCHER Phase II trial of ANX007 in patients with geographic atrophy (GA) demonstrated a statistically significant, dose-dependent preservation ...
Ophthalmic Revenue Roundup for Carl Zeiss Meditec and Hoya
Carl Zeiss Meditec reported May 9 that its ophthalmic device revenue for the first three months of 2023 (the second quarter of its fiscal 2022/2023 year) totaled €384.4 million ($421 million, conve...
Washington Governor Signs Law Expanding Scope of Practice for Optometrists
Gov. Jay Inslee of Washington state on May 9 signed the Access to Eyecare Act, expanding the scope of practice for optometrists there to include: —Incision and excision of chalazion —Certain inject...
Eyecelerator Draws Record Crowd Ahead of ASCRS Meeting
Eyecelerator had the largest attendance at an ASCRS Eyecelerator meeting to date, with over 600 industry, investment, and clinical attendees registered for the event. The first panel of the day fea...
Envision Healthcare, Amsurg to Separate Following Bankruptcy Filing
KKR-backed Envision Healthcare reported May 15 that it had filed for Chapter 11 bankruptcy protection. The Nashville, Tennessee, company said it had entered into a restructuring support agreement w...
Lumibird to Acquire Prima Industrie’s High-Power Laser and Semiconductor Businesses
France-based Lumibird announced May 16 that it and Italy’s Prima Industrie had agreed on a deal for Lumibird to acquire Prima subsidiary Convergent Photonics, also of Italy, and the Convergent asse...
Mireca Reacquires All Rights to Retinal Candidates as Graybug, Now CalciMedica, Exits Ophthalmology
Germany’s Mireca Medicines announced May 24 that it had regained all intellectual property rights previously shared in a partnership with Graybug Vision, now CalciMedica. Graybug, of Redwood City, ...
iHealthScreen Files for US FDA 510(k) Clearance for iPredict AI Screener in AMD
New York-based iHealthScreen announced May 23 that it had submitted its iPredict automated AI screening system for US FDA 510(k) clearance for early diagnosis of age-related macular degeneration (A...
PharmAbcine Gets Green Light from Korean Regulators for Phase I Trial of Wet AMD Candidate
South Korea’s PharmAbcine announced May 23 that Korean regulators had cleared its investigational new drug application for a Phase I trial of PMC-403, the company’s candidate for wet age-related ma...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.